Quick Answer
Autonomix Medical, Inc. reported Stockholders Equity of $8.10 million for the year ending 2025.
- Autonomix Medical, Inc. showed an increase of +6.2% in Stockholders Equity from 2024 to 2025.
- This data is from Autonomix Medical, Inc.'s annual report (Form 10-K), filed with the SEC on May 29, 2025.
- XBRL data for this metric is available from 2022 to 2025 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2022: $1.62 million | Q3 2022: $1.17 million | Q4 2022: $626.0 thousand | Q2 2023: $2.62 million | Q3 2023: -$2.92 million | Q4 2023: -$5.60 million | Q1 2024: $7.63 million | Q2 2024: $5.29 million | Q3 2024: $3.03 million | Q4 2024: $9.71 million | Q1 2025: $8.10 million | Q2 2025: $7.03 million | Q3 2025: $6.45 million | Q4 2025: $8.56 million.
- Over the full 4 years of available data (2022 to 2025), Autonomix Medical, Inc.'s Stockholders Equity has grown by 313.4%.
- Historical annual values: Fiscal year 2025: $8.10 million | Fiscal year 2024: $7.63 million | Fiscal year 2023: $644.0 thousand | Fiscal year 2022: $1.96 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: